Insider Transactions in Q3 2024 at Veracyte, Inc. (VCYT)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 19
2024
|
Evan/ Fa Jones Director |
SELL
Open market or private sale
|
Indirect |
5,173
-100.0%
|
$181,055
$35.23 P/Share
|
|
Sep 04
2024
|
John Leite Chief Commercial Officer-CLIA |
SELL
Open market or private sale
|
Direct |
5,479
-6.71%
|
$158,891
$29.78 P/Share
|
|
Sep 03
2024
|
David Brent Shafer Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,507
+50.0%
|
-
|
|
Sep 03
2024
|
Thomas F. Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,507
+50.0%
|
-
|
|
Sep 02
2024
|
Rebecca Chambers Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,464
-2.42%
|
$107,384
$31.55 P/Share
|
|
Sep 02
2024
|
Annie Mc Guire SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,920
-2.01%
|
$59,520
$31.55 P/Share
|
|
Sep 02
2024
|
Jonathan Wygant VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,087
-2.24%
|
$33,697
$31.55 P/Share
|
|
Sep 02
2024
|
Marc Stapley Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,748
-1.77%
|
$178,188
$31.55 P/Share
|
|
Sep 02
2024
|
John Leite Chief Commercial Officer-CLIA |
SELL
Payment of exercise price or tax liability
|
Direct |
1,315
-1.58%
|
$40,765
$31.55 P/Share
|
|
Aug 13
2024
|
Evan/ Fa Jones Director |
SELL
Open market or private sale
|
Indirect |
27,188
-35.2%
|
$870,016
$32.1 P/Share
|
|
Aug 13
2024
|
Evan/ Fa Jones Director |
SELL
Open market or private sale
|
Direct |
20,457
-13.26%
|
$654,624
$32.11 P/Share
|
|
Aug 13
2024
|
Evan/ Fa Jones Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,486
+13.41%
|
$84,860
$10.41 P/Share
|
|
Aug 12
2024
|
Evan/ Fa Jones Director |
SELL
Open market or private sale
|
Indirect |
101
-0.31%
|
$3,030
$30.0 P/Share
|
|
Aug 12
2024
|
Evan/ Fa Jones Director |
SELL
Open market or private sale
|
Direct |
99
-0.21%
|
$2,970
$30.01 P/Share
|
|
Aug 09
2024
|
Evan/ Fa Jones Director |
SELL
Open market or private sale
|
Indirect |
746
-2.25%
|
$22,380
$30.03 P/Share
|
|
Aug 09
2024
|
Evan/ Fa Jones Director |
SELL
Open market or private sale
|
Direct |
1,032
-2.18%
|
$30,960
$30.03 P/Share
|
|
Aug 09
2024
|
Evan/ Fa Jones Director |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+0.63%
|
$3,000
$10.41 P/Share
|
|
Aug 07
2024
|
Evan/ Fa Jones Director |
SELL
Open market or private sale
|
Direct |
5,108
-10.16%
|
$153,240
$30.32 P/Share
|
|
Aug 07
2024
|
Evan/ Fa Jones Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,214
+2.36%
|
$12,140
$10.41 P/Share
|
|
Aug 07
2024
|
Jens Holstein Director |
SELL
Open market or private sale
|
Direct |
5,000
-7.92%
|
$145,000
$29.0 P/Share
|
|
Jul 16
2024
|
Jens Holstein Director |
SELL
Open market or private sale
|
Direct |
5,000
-6.83%
|
$120,000
$24.5 P/Share
|
|
Jul 16
2024
|
John Leite Chief Commercial Officer-CLIA |
SELL
Open market or private sale
|
Direct |
1,277
-1.52%
|
$31,925
$25.0 P/Share
|
|
Jul 16
2024
|
Karin Eastham Director |
SELL
Open market or private sale
|
Direct |
7,500
-18.41%
|
$187,500
$25.0 P/Share
|